Takeshi Ueda

7PUBLICATIONS
20CO-AUTHORS
Respiratory diseasesPredictive and prognostic markersMedical devicesCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 25, 2025
JMJD3-mediated senescence is required to overcome stress-induced hematopoietic defects.

Yuichiro Nakata, Takeshi Ueda, Yasuyuki Sera

|Feb 12, 2024
Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer.

Suman Dash, Takeshi Ueda, Akiyoshi Komuro

|Jul 31, 2023
MBTD1 preserves adult hematopoietic stem cell pool size and function.

Keiyo Takubo, Phyo Wai Htun, Takeshi Ueda

|Feb 09, 2023
MYC/Glutamine Dependency Is a Therapeutic Vulnerability in Pancreatic Cancer with Deoxycytidine Kinase Inactivation-Induced Gemcitabine Resistance.

Suman Dash, Takeshi Ueda, Akiyoshi Komuro

|Dec 23, 2021
KDM4B promotes acute myeloid leukemia associated with AML1-ETO by regulating chromatin accessibility.

Takeshi Ueda, Akinori Kanai, Akiyoshi Komuro

Pageof 2

Frequent Collaborators

3 joint publications

Suman Dash

3 joint publications

Hitoshi Okada

3 joint publications

Keiyo Takubo

3 joint publications

Hiroaki Honda